Artivion amends agreements with Endospan (NYSE:AORT)

  • Artivion (NYSE:AORT) on Monday said it has amended its credit facility and option purchase agreements with Endospan.
  • Through the agreement, Artivion will provide Endospan with $25M of additional debt funding to obtain FDA approval for NEXUS.
  • The amendment to the

Source link

Related Articles

Back to top button